Bank Of America Corp Krystal Biotech, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 93,629 shares of KRYS stock, worth $18.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,629

Previous 75,844 23.45%

Holding current value

$18.9 Million

Previous $13.5 Million 27.42%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $2.72 Million - $3.27 Million	17,785 Added 23.45%	93,629 $17.2 Million
Q1 2024 May 15, 2024	SELL	$108.01 - $179.35 $1.66 Million - $2.75 Million	-15,349 Reduced 16.83%	75,844 $13.5 Million
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $4.65 Million - $6.21 Million	48,423 Added 113.22%	91,193 $11.3 Million
Q2 2023 Aug 14, 2023	SELL	$78.48 - $130.32 $3.93 Million - $6.53 Million	-50,117 Reduced 53.95%	42,770 $5.02 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $1.8 Million - $2.09 Million	24,844 Added 36.51%	92,887 $7.44 Million
Q4 2022 Feb 10, 2023	BUY	$63.14 - $79.9 $1.68 Million - $2.13 Million	26,679 Added 64.5%	68,043 $5.39 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $170,360 - $216,464	2,627 Added 6.78%	41,364 $2.88 Million
Q2 2022 Aug 12, 2022	SELL	$48.93 - $73.47 $188,771 - $283,447	-3,858 Reduced 9.06%	38,737 $2.54 Million
Q1 2022 May 16, 2022	BUY	$51.99 - $72.11 $1.53 Million - $2.12 Million	29,386 Added 222.47%	42,595 $2.83 Million
Q4 2021 Feb 08, 2022	BUY	$39.81 - $88.24 $242,801 - $538,175	6,099 Added 85.78%	13,209 $924,000
Q3 2021 Nov 15, 2021	SELL	$52.01 - $71.77 $57,211 - $78,947	-1,100 Reduced 13.4%	7,110 $370,000
Q2 2021 Sep 13, 2021	BUY	$62.14 - $81.82 $510,169 - $671,742	8,210 New	8,210 $558,000

Others Institutions Holding KRYS

# of Institutions

266

Shares Held

25M

Call Options Held

270K

Put Options Held

172K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.17B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Krystal Biotech, Inc. Transaction History